<DOC>
	<DOC>NCT01375374</DOC>
	<brief_summary>The purpose of the trial is to investigate whether changes in lipids and hormonal parameters can be observed in blood when Carbamazepine treatment is replaced with Lacosamide treatment, while Levetiracetam treatment remains unchanged.</brief_summary>
	<brief_title>Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide</brief_title>
	<detailed_description />
	<mesh_term>Epilepsies, Partial</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Male subject with diagnosis of Epilepsy with PartialOnset Seizures Subject only taking Levetiracetam in combination with Carbamazepine as adjunctive treatment for Epilepsy Subject is taking another AntiEpileptic Drug (AED) than Carbamazepine (CBZ) and Levetiracetam (LEV) Subject is taking lipid lowering agents Subject is taking enzyme inducers</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Vimpat</keyword>
	<keyword>Partial seizures</keyword>
	<keyword>Carbamazepine</keyword>
	<keyword>Hormone levels</keyword>
	<keyword>Lipid levels</keyword>
	<keyword>Lacosamide</keyword>
</DOC>